期刊
NATURE METHODS
卷 10, 期 1, 页码 28-34出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nmeth.2309
关键词
-
资金
- Broad Institute of MIT and Harvard
- US National Cancer Institute part of the Clinical Proteomics Tumor Analysis Consortium initiative [U24CA160034]
- National Heart, Lung, and Blood Institute [HHSN268201000033C, R01HL096738]
- Entertainment Industry Foundation
- Komen Foundation
- NATIONAL CANCER INSTITUTE [U24CA160034] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096738] Funding Source: NIH RePORTER
Targeted mass spectrometry (MS) is becoming widely used in academia and in pharmaceutical and biotechnology industries for sensitive and quantitative detection of proteins, peptides and post-translational modifications. Here we describe the increasing importance of targeted MS technologies in clinical proteomics and the potential key roles these techniques will have in bridging biomedical discovery and clinical implementation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据